Market news
Plexus (NASDAQ:PLXS) has outperformed the market over the past 5 years by 11.44% on an annualized basis producing an average annual return of 23.43%. Currently, Plexus has a market capitalization of $6.93 billion.
Plexus posts 28% revenue growth, but valuation looks full at 26.4x forward P/E. Click to learn more about PLXS' risks and why free cash flow is key.
Analysts upgraded MetLife, Brinker, Plexus, West Pharma and Omeros, raising ratings and price targets.
Plexus (PLXS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Detailed price information for Plexus Corp (PLXS-Q) from The Globe and Mail including charting and trades.
PLXS' broad Q3 beat and stronger growth outlook extend its runway, but rising working-capital needs put free cash flow conversion under scrutiny.
Plexus Corp (PLXS) delivers record Q3 revenue of $1.305 billion, raises fiscal 2026 outlook to over 20% growth, and anticipates continued momentum into fiscal 2027.
Top Wall Street analysts upgraded IP, AXTI, REPL, and PLXS stocks with higher price targets. See what other analysts think about these stocks.
PLXS beats fiscal Q3 estimates as revenues jump 28%, fueled by Industrial strength, program ramps and broad demand, while its outlook signals more growth.
Moby summary of Plexus Corp.'s Q3 2026 earnings call
Although the revenue and EPS for Plexus (PLXS) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Detailed price information for Plexus Corp (PLXS-Q) from The Globe and Mail including charting and trades.
This is the newest page. Registered accounts read further back.